We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Health Effects From Removal of Amalgam Restorations in Patients With Symptoms Allegedly Related to Dental Amalgam

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00346944
First Posted: July 4, 2006
Last Update Posted: August 28, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Uni Research
Information provided by (Responsible Party):
Lars Bjorkman, Uni Research
  Purpose
The aim of the project is to study changes in symptom load after removal of all dental amalgam restorations in patients with symptoms allegedly related to amalgam.

Condition Intervention Phase
Adverse Effects Dental Restoration, Permanent Procedure: Removal of dental amalgam restorations Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Factorial Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Health Effects From Removal of Amalgam Restorations in Patients With Symptoms Allegedly Related to Dental Amalgam - A Study of Patients Examined at the Dental Biomaterials Adverse Reaction Unit in 1993 to 1999

Further study details as provided by Lars Bjorkman, Uni Research:

Primary Outcome Measures:
  • Changes of subjective health complaints [ Time Frame: Five years ]
  • Changes over time of the MMPI-profile [ Time Frame: Five years ]
  • Quality of life improvement [ Time Frame: Five years ]

Secondary Outcome Measures:
  • Reduction of mercury in blood serum [ Time Frame: One year ]

Enrollment: 50
Study Start Date: September 2002
Study Completion Date: March 2010
Primary Completion Date: March 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Treatment group Procedure: Removal of dental amalgam restorations
Removal of dental amalgam restorations by patient's own dentist. Fillings will be replaced with e.g. resin based filling material, metalloceramic restorations, and ceramic materials. Rubber dam will be used during removal of amalgam restorations.
No Intervention: Reference group

Detailed Description:
Patients referred from dentists and physicians in the period 1993 to 1999 to the Dental Biomaterials Adverse Reaction Unit, Department of Health, UNIFOB AS, for symptoms related to amalgam restorations are randomized into treatment group (n=20) or reference group (n=20). All patients in the treatment group are followed 3, 12, 36 and 60 months after completion of amalgam removal with questionnaires on health outcomes, Minnesota Multiphasic Personality Inventory-2 (MMPI-2) and laboratory tests.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   25 Years to 55 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Referred for examination of general health complaints related to amalgam
  • Health complaints from at least three different organ systems
  • Dental amalgam restorations present
  • Data available on concentration of mercury in blood and urine at the initial examination
  • Patient agreed to be contacted after the examination

Exclusion Criteria:

  • Serious disease (incl. severe allergy to foodstuff and severe rheumatoid arthritis)
  • Mental instability or psychiatric disease
  • Cases with complicated dental rehabilitation (incl. bridge prostheses)
  • Allergy to dental replacement materials
  • Severe periodontitis
  • High caries activity
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00346944


Locations
Norway
UNIFOB AS, Dental Biomaterials Adverse Reaction Unit
Bergen, Norway, NO-5009
Sponsors and Collaborators
University of Bergen
Uni Research
Investigators
Principal Investigator: Lars Björkman, DDS, PhD University of Bergen